RxDoctor Payments Data

Jamie Abbott, MD

Dermatology · Fayetteville, ARNPI 1578958716

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 94.0% of the total across 244 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 20 manufacturers reported payments, led by AbbVie at 36.9% of the total. 2025 is the largest year on record at $1,428, more than ten times the $81 reported in 2019.

$4,458in general payments, 2019–2025

Across 244 payments — averaging $18.27 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$2K
  • Lilly USA, LLC$458
  • Sanofi$348
  • Johnson & Johnson$268
  • Sun Pharmaceutical Industries Inc.$264
  • UCB, Inc.$250
  • plus $1K from 14 others

What the payments were for

  • Food & beverage$4,19094%
  • Education$2686%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$4,458 in reported general payments places this provider in the 55th percentile of 75 dermatology providers in Arkansas.

See all dermatology providers in Arkansas

Medicare billing

Part B allowed, 2024
$788,905
Medicare patients
884
Services billed
8,629

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Taltz AutoinjectorIxekizumab19$147,581
Clobetasol Propionate146$9,795
Metronidazole34$2,333
Triamcinolone Acetonide175$1,902
Fluorouracil23$1,607
Tretinoin16$1,344
Ketoconazole78$1,312
Betamethasone Diprop AugmentedBetamethasone/Propylene Glyc18$1,221
Clindamycin Phosphate32$1,148
Betamethasone Dipropionate22$1,005
Doxycycline Hyclate49$980
Mupirocin115$777
Finasteride64$637
Minocycline Hcl23$583
ValacyclovirValacyclovir Hcl22$529

Paid to pharmacies, not to this prescriber.

Other dermatology in Fayetteville

See the full list for Arkansas

Where these figures come from

Is this you, or does something look wrong? →